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Salmonid alphavirus (SAV) is the OIE-listed, viral cause of pancreas disease (PD)
in farmed Atlantic salmon. SAV is routinely detected by PCR–methods while typical
histopathological lesions are additionally used to confirm the diagnosis. Field evaluation
of diagnostic test performance is essential to ensure confidence in a test’s ability to
predict the infection or disease status of a target animal. For most tests used in
aquaculture, characteristics like sensitivity (Se) and specificity (Sp) at the analytical level
may be known. Few tests are, however, evaluated at the diagnostic level according to
the OIE standard. In the present work, we estimated diagnostic test sensitivity (DSe)
and diagnostic test specificity (DSp) for five laboratory tests used for SAV detection.
As there is no gold standard, the study was designed using Bayesian latent class
analysis. Real-time RT-PCR, cell culture, histopathology, virus neutralization test, and
immunohistochemistry were compared using samples taken from three different farmed
Atlantic salmon populations with different infection status; one population regarded
negative, one in an early stage of infection, and one in a later stage of infection. The
average fish weight in the three populations was 2.0, 1.6, and 1.5 kg, respectively. The
DSe and DSp of real-time RT-PCR is of particular interest due to its common use as
a screening tool. The method showed high DSe (≥0.977) and moderate DSp (0.831)
in all 3-populations models. The results further suggest that a follow-up test of serum
samples in real-time RT-PCR negative populations may be prudent in cases where
epidemiological information suggest a high risk of infection and where a false negative
result is of high consequence. This study underlines the need to choose a test appropriate
for the purpose of the testing. In the case of a weak positive PCR-result, a follow-up test
should be conducted to verify the presence of SAV. Cell culture showed high DSe and
DSp and may be used to verify viral presence.
Keywords: salmonid alphavirus, pancreas disease, Atlantic salmon, Bayesian latent class analysis, real-time
RT-PCR, diagnostic sensitivity, diagnostic specificity
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INTRODUCTION
The ability to reliably detect the presence of important infectious
disease agents in aquatic animal populations is essential for such
diverse reasons as disease surveillance and international trade. All
member countries of the World Organization for Animal Health
(OIE) are obliged to provide timely and transparent information
on its situation on listed animal diseases, information that
plays an important part in relation to international trade and
trade partner trust. The evaluation of a diagnostic test for its
performance is essential to ensure confidence in the test’s ability
to accurately predict the infection or exposure status of the
target animal (1). An important stage in OIE’s test development
and validation pathway is the validation of a test’s diagnostic
sensitivity (DSe) and diagnostic specificity (DSp) under field
conditions (2), using a reference or gold standard test i.e., a
diagnostic test which correctly identifies all true positive animals
as positive and all true negative animals as negative.
The DSe in a veterinary context is the conditional probability
that an infected animal will be test-positive, while DSp is the
conditional probability that an uninfected animal will be test-
negative (1). A gold standard test does not always exist or might
not be available for field conditions. One alternative analytical
tool for estimation of DSe and DSp is Bayesian latent class
analysis (3, 4). The Bayesian approach for estimating diagnostic
test accuracy does not require knowledge of true infection status
and allows for the incorporation of prior scientific knowledge,
such as disease prevalence in study populations, when specifying
model parameters. Both prior information and new, collected
data can then be used to assess diagnostic test performance.
The models provide posterior distributions of the parameters of
interest e.g., the median and 95% probability interval for test DSe
and DSp.
The test performance (DSe and DSp), which are the properties
of the diagnostic tool, are not subject to change with prevalence.
However, DSe and DSp can be influenced by individual
characteristics, and so the estimates can differ when applied to
populations under different stages of infection e.g., infection
during a long latent period or chronic infection. Bayesian
latent class analysis is a robust method which has been widely
used for the estimation of diagnostic test performance when a
gold standard test does not exist. It is also the only method
for combining existing knowledge and expert opinions into
equations. However, there have been very few uses of the method
in the field of aquatic animal diseases (5–8).
The Norwegian salmonid aquaculture industry is largely
relying on foreign markets for its products and according to
the Norwegian Seafood Council, one million metric tons of
salmon was exported from Norway in 2017 (9). One of the
major disease challenges affecting the Norwegian production
is the OIE-listed viral agent salmonid alphavirus (SAV), with
around 140–160 new grow-out populations being infected every
year (10). There are six known genotypes of SAV (11), and the
geographical distribution of the two endemic SAV-genotypes
present in Norway, SAV3 and marine SAV2, are partially
overlapping (12–14). As reviewed by Jansen et al. (14) infected
fish commonly present with reduced appetite and abnormal
swimming behavior prior to the onset of mortality. Post-mortem
inspection commonly reveals empty intestines, fecal casts and
signs of circulatory disturbance. On histological examination,
major lesions include loss of exocrine pancreatic tissue, cardiac
myocytic necrosis, and inflammation and degeneration of
skeletal muscle. While mortality levels have been reported to be
significantly higher in populations affected by SAV3 than marine
SAV2 both during experimental- and field studies (15, 16), the
histopathological changes appear similar regardless of underlying
SAV genotype (16, 17). A proportion of surviving fish may
develop severe fibrosis of the peri-acinar tissue and subsequently
fail to grow (17). Clinical signs and macroscopic changes are
not in themselves pathognomonic, and thus a diagnosis depends
on the application of laboratory diagnostic tests (17). Subclinical
infections of SAV occur (18, 19), and variation in prevalence due
to SAV genotype has been reported. In Norway, infections with
marine SAV2 are reported to generate a higher proportion of
subclinical cases than SAV3 infections (15).
The OIE disease card for SAV lists a number of laboratory
tests that have been deemed appropriate for diagnostic
purposes for detection of SAV or histopathological changes
consistent with SAV infection (20). These include real-time RT-
PCR, conventional RT-PCR (with sequencing for genotyping),
immunohistochemistry, histopathology, serum neutralization
assay, and isolation of virus in cell culture. A serum-based
selective precipitation reaction (SPR) has also been recently
described (21), however this is currently not in use in Norway
and is not listed on the OIE disease card.
There has been a lack of scientific field-validation of the
diagnostic tests used in conjunction with SAV detection and
histopathological changes consistent with SAV infection in
Norway. In the autumn of 2017 Norway introduced a new
screening protocol where all salmonid seawater grow-out sites
that are stocking fish are sampled monthly for the detection
of SAV by real-time RT-PCR until SAV is eventually detected
or the population is slaughtered. As a result, an evaluation of
the DSe and DSp of the applied diagnostic tests in general, and
the real-time RT-PCR in particular, is of interest to a range of
stakeholders including the government, the competent authority,
and the industry. The aim of this study was therefore to evaluate
the field performance of the available diagnostic tests for SAV in
Norway assuming there was no gold standard.
MATERIALS AND METHODS
Source Populations and Sampling
Procedures
Three Atlantic salmon seawater grow-out sites were included in
this study. The sites were purposely selected on the basis of the
assumed infection status of their populations; one non-infected
population and two SAV-infected populations at different stages
of infection.
Site 1 was located in the eastern part of the northernmost
county of Norway (Finnmark), a county with no SAV detections
since 2013 and without any previous SAV detections in its eastern
part. This site was therefore assumed to stock a non-infected
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population, and the site was sampled in May 2017. At the time of
sampling, the site stocked ∼1.5 million fish at an average weight
of∼2 kg.
Site 2 was located in south-western Norway (Hordaland
county), an area that has a high prevalence of SAV3-infected sites.
Following routine disease investigation procedures, the site was
diagnosed with SAV3 PD (SAV3 detection and histopathological
changes indicative of SAV infection in the same individual) in
May 2017 and was sampled for this study in the same month.
The fish population had been vaccinated with a commercially
available SAV vaccine (based on SAV1). The fish were transferred
to sea in September 2016, and at time of sampling the site stocked
∼1 million fish at an average weight of ∼1.6 kg. There was no
major clinical disease outbreak at the time of sampling.
Site 3 was located in mid-Norway (Møre and Romsdal
county), an area that has a high prevalence of SAV2-infected
sites. The site was diagnosed with SAV2 PD (SAV2 detection
and histopathological changes indicative of SAV infection in the
same individual) in February 2017, and sample collection was
performed in June 2017. The fish population was not vaccinated
against SAV. The fish were transferred to sea in September 2016,
and at time of sampling, the site stocked ∼630,000 fish at an
average weight of ∼1.5 kg. There was no major clinical disease
outbreak after the diagnosis date until the time of sampling.
Sampling procedures were similar at all three sites. One cage
was selected at each site; a randomly selected cage at Site 1 and
a cage where PD had been diagnosed at Site 2 and Site 3. One
hundred fish were convenience sampled from each cage using
a seine net. All fish were sedated and subsequently humanely
euthanized by a blow to the head. Based on the sampling
procedures outlined by the Norwegian Veterinary Institute (22),
the following set of samples were aseptically collected from
each fish: tissue samples in RNAlaterTM (head kidney, heart
ventricle), in 10% buffered formalin (NVI, product number
30.054.08) (gill, head kidney, heart ventricle, liver, pancreas, red
and white muscle, spleen) and in viral transport medium (NVI,
product number 50.008.00) (head kidney, heart ventricle), and
blood samples on standard tubes for serological investigation
(BD PlastipakTM 2ml syringes with 21G needles). Samples were
stored on ice until arrival at the laboratory storage facilities.
Diagnostic Tests
Samples from each fish were tested at the Norwegian Veterinary
Institute laboratory for the presence of SAV, SAV antibodies or for
typical histopathological lesions consistent with SAV infection
by five different diagnostic tests, namely real-time RT-PCR,
isolation in cell culture, virus neutralization test, histopathology,
and immunohistochemistry. See Table 1 for details on the test
purpose, target tissue, and classification criteria of test-positive
and test-negative samples.
Real-Time RT-PCR (PCR)
For the detection of SAV-RNA in heart and kidney tissues, a
real-time RT-PCR assay was used to test for the presence of
the conserved SAV Qnsp1 gene as described by Hodneland and
Endresen (23), with some modifications. Briefly, nucleic acids
were extracted using the NucliSens R© easyMAGTM (bioMérieux)
TABLE 1 | Test purpose, target tissue and criteria for positive and negative results
for the five evaluated diagnostic tests.
Test Test purpose Target tissue Positive
result
Negative
result
PCR Detection
of SAV-RNA
Heart
ventricle
Head kidney
Ct-value < 40 Ct-value ≥ 40
No Ct-
value obtained
CELL Isolation of SAV Heart
ventricle
Head kidney
SAV infection
of cells
No SAV
infection of
cells
NT Detection of
antibodies/neutralizing
activity
against SAV
Serum Virus
neutralization
at 1:20
dilution only
or at both
1:20 and
1:80 dilutions
No virus
neutralization
HIST Detection of
pathological
lesions consistent
with SAV infection
Heart
ventricle
Pancreas
Red and
white muscle
Lesions
consistent
with, or
indicative of,
SAV infection
No lesions
indicative of
SAV infection
IHC Detection of SAV Pancreas Positive
staining of
necrotic
exocrine
pancreatic cells
No staining of
exocrine
pancreatic
cells
system according to themanufacturer’s instructions. The Brilliant
III Ultra-Fast QRT-PCR (Agilent Technologies) master mix
was used according to the manufacturer’s instructions and
amplification was performed using a Stratagene Mx3005P system
(Agilent Technologies) over 40 cycles. Reactions with a cycle
threshold (Ct) < 40 were considered positive. The Qnsp1 assay
is capable of detecting all currently known SAV genotypes and, as
a result, all SAV-positive populations will have the SAV genotype
determined by subsequent sequencing.
Isolation in Cell Culture (CELL)
SAV isolation from tissue samples was performed as previously
described by Jansen et al. (24) and inoculated in 1:10 and 1:80
dilutions onto Chinook salmon embryo culture (CHSE-214)
plates which had been grown at 20◦C. After 2 weeks of incubation
at 15◦C, the plates were freeze-thawed and the cell lysate were
inoculated on new cell cultures and incubated for a further 2
weeks. As the Norwegian field isolates of SAV2 and SAV3 rarely
induce CPE in CHSE-214 cells, indirect immunofluorescence
antibody test (IFAT) was used to visualize SAV-infected cells.
Briefly, a 96-well CHSE plate was inoculated with cell culture
supernatants and incubated at 15◦C for 10 days. After fixation
in 80% acetone, 50 µl of diluted SAV-specific mouse monoclonal
antibody 17H23 directed against the E2 glycoprotein (25) was
added per well and incubated for 1 h, followed by subsequent
incubation for 1 h with diluted secondary biotinylated goat
anti-mouse IgG antibody (DAKO) before the final incubation
with streptavidin-fluorescein isothiocyanate (FITC) conjugate
(eBioscience). Stained cell cultures were examined on an inverted
fluorescencemicroscope. Positive samples were those with two or
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more fluorescent cells in at least two parallel wells and where the
negative controls did not show any fluorescent cells.
Virus Neutralization Test (NT)
The presence of SAV neutralizing antibodies in fish serum
samples was tested for using a virus neutralization test as
described by Graham et al. (26) with modifications as described
by Taksdal et al. (27). Briefly, plasma samples diluted to 1:20 and
1:80 were mixed with equal parts of a SAV1 reference strain (F93-
125, Ireland) and incubated for 2 h at room temperature before
inoculation onto 96-well CHSE plates. A 1:20 serum dilution
without virus was used as the control. Plates were incubated for
12 days before IFAT staining, as described in section Isolation in
Cell Culture (CELL). Virus neutralization at antibody titres≥1:20
were considered positive.
Histopathological Examination (HIST)
Tissue samples were examined for histopathological changes
consistent with SAV infection as described by Taksdal et al.
(16). Samples were fixed with formaldehyde, and 4–6µm
hemotoxylin and eosin stained sections were examined under
a light microscope. Samples were classified as either showing
(1) changes consistent with SAV infection, (2) changes that
might indicate SAV infection, or (3) no changes consistent
with SAV infection. Samples with changes consistent with SAV
infection or changes that might indicate SAV infection were
considered positive.
Immunohistochemistry (IHC)
Detection of SAV in tissues by immunohistochemistry was
performed as described by Taksdal et al. (27). Briefly, after
blocking non-specific antibody binding sites, primary anti-SAV
mAb was diluted to 1:3,000 and added to the tissue samples
before overnight incubation at room temperature. Tissues were
incubated with a 1:300 dilution of secondary biotinylated rabbit
anti-mouse IgG and IgM before further incubation with a
1:500 dilution of streptavidin-alkaline phosphatase complex
at room temperature. Tissue sections were stained with fast
red salt in fast red substrate solution and examined under a
light microscope for antibody-antigen binding. Samples with
positive staining of necrotic exocrine pancreatic cells were
considered positive.
Estimation of Test Diagnostic Sensitivity
and Specificity
Bayesian Latent Class Analysis
Bayesian latent class analysis was used to estimate the test
performance characteristics (DSe and DSp) of the five tests,
assuming that none of these tests could be considered
as a gold standard. The model was modified from the
study of bacterial kidney disease test accuracy (6) and
the code was provided by Jaramillo et al. (6). The study
followed the guidelines for diagnostic test evaluation as
described by Laurin et al. (28) and consulted the standards
for the reporting of diagnostic accuracy studies that use
Bayesian latent class models as described by Kostoulas
et al. (29).
In this study, non-informative priors were assumed for the
sensitivity and specificity of all five tests considering that the
test characteristics have not previously been established and
was implemented using a flat beta distribution: beta (1,1). The
existing knowledge of SAV infection status was incorporated
as informative priors for Site 1 and Site 2 prevalence. The fish
health veterinarians responsible for health monitoring on the
study sites were asked to provide the most likely value, and
lower or upper limit of the site prevalence, before the samples
were collected. The prior for Site 1 SAV-prevalence reflects the
assumption that the site was likely to be uninfected, and the
most likely number of positive fish would be 1 in 100,000 fish,
with an upper limit of 10 in 100,000 fish. The prior of site 2
prevalence was chosen to reflect the knowledge that the site was
infected. Site 2 was sampled in the same month as the diagnosis
and could therefore either be heavily infected, if infection had
been undetected for a while, or have an increasing prevalence.
The most likely prevalence was assumed to be 60% with a large
uncertainty ranging between 5 and 95%. Site 3 was sampled 4
months after diagnosis and could therefore either be moderately
infected or have a low infection prevalence due to recovery.
Due to this uncertainty about the most likely prevalence value
for Site 3, a non-informative prior was assumed. The priors
of Site 1, Site 2, and Site 3 prevalence were modeled using a
beta distribution of beta (2, 100,000), beta (6,4), and beta (1,1),
respectively (Table 2).
In this study, seven models with different number of tests
and number of populations were evaluated. The main model
(model 1) was a model with 3-populations and 5-tests where
the samples from all sites and all tests were included. Models 2
and 3 were models with 3-populations and 4-tests, while model
4 was a model with 3-populations and 3-tests. Models 5, 6, 7
were models with 2-populations and 5-tests. Details of which
populations and tests that were included in each model are
presented inTable 3. For biological reasons, potential conditional
dependencies between PCR and CELL, and between HIST and
IHC, were investigated by estimation of covariance of DSe and
DSp for each pair of the tests when possible.
Model convergence was assessed using graphical diagnostics
by running the models with multiple chains of different
initial values and checking the trace plots for each parameter.
Convergence was further tested for all parameters by Gelman-
Rubin statistics (R-hat) < 1.1 (30) using the CODA package in
R (https://cran.r-project.org/web/packages/coda/coda.pdf) and
TABLE 2 | Prior information used in the models for site prevalence and diagnostic
sensitivity and specificity of all five tests.
Parameter Expert opinion Prior distribution
Most likely Lower limit Upper limit
Site 1 prevalence 1/100,000 – 10/100,000 Beta(2,100,000)
Site 2 prevalence 60% 5% 95% Beta(6,4)
Site 3 prevalence – – – Beta(1,1)
DSe of all tests – – – Beta(1,1)
DSp of all tests – – – Beta(1,1)
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TABLE 3 | List of the seven evaluated models with their prior distributions, and the changes to the model priors for sensitivity analysis.
Model Populations Tests Defaults priors
Site 1 prevalence Site 2 prevalence Site 3 prevalence DSe of all tests DSp of all tests
1 Sites 1,2,3 PCR, CELL, NT, HIST, IHC Beta(2,100,000) Beta(6,4) Beta(1,1) Beta(1,1) Beta(1,1)
2 Sites 1,2,3 PCR, CELL, HIST, IHC Beta(2,100,000) Beta(6,4) Beta(1,1) Beta(1,1) Beta(1,1)
3 Sites 1,2,3 PCR, CELL, NT, HIST Beta(2,100,000) Beta(6,4) Beta(1,1) Beta(1,1) Beta(1,1)
4 Sites 1,2,3 PCR, CELL, HIST Beta(2,100,000) Beta(6,4) Beta(1,1) Beta(1,1) Beta(1,1)
5 Sites 2, 3 PCR, CELL, NT, HIST, IHC n/a Beta(6,4) Beta(1,1) Beta(1,1) Beta(1,1)
6 Sites 1, 2 PCR, CELL, NT, HIST, IHC Beta(2,100,000) Beta(6,4) n/a Beta(1,1) Beta(1,1)
7 Sites 1, 3 PCR, CELL, NT, HIST, IHC Beta(2,100,000) n/a Beta(1,1) Beta(1,1) Beta(1,1)
Model Sensitivity analysis (SA) Changes in priors
1 SA1 – Beta(1,1) – – –
1 SA2 Beta(6,100,000) Beta(1,1) – – –
2 SA3 – Beta(1,1) – – –
2 SA4 Beta(6,100,000) Beta(1,1) – – –
3 SA5 – Beta(1,1) – – –
3 SA6 Beta(6,100,000) Beta(1,1) – – –
4 SA7 – Beta(1,1) – – –
4 SA8 Beta(6,100,000) Beta(1,1) – – –
Bayesian p-value was estimated to assess the model goodness-
of-fit. The models were coded in OpenBUGS, v3.2.3 rev
1012 (31). Each model was run for 100,000 iterations of
which the first 10,000 iterations were discarded as burn-
in. Thinning by 10 was applied to eliminate autocorrelation.
Model outputs are presented as the posterior median and
95% probability intervals (2.5th and 97.5th percentiles) and
as boxplots of the posterior estimates of site prevalence, DSe
and DSp.
Difference of DSe and DSp Between Tests
Differences beyond chance of the DSe and DSp between tests
were assessed using a built-in step function in OpenBUGS to
estimate the probability of the differences between tests for which
a probability >0.05 was considered significant. The process was
performed using default values of model 1, and focused on
selected pairs of tests for which the difference was not determined
by visualization alone.
Sensitivity Analysis
The effect of changing priors on the estimated DSe and DSp of
all tests was evaluated by replacing prior of Site 2 with non-
informative prior, and shifting the prior distribution of Site 1
prevalence by 30% from the median default value (Table 3).
Ethical Approval
This study was performed in accordance with the ethical
guidelines of the Norwegian Veterinary Institute. All fish were
sedated and humanely euthanized prior to sample collection in
accordance with standard procedures.
TABLE 4 | Summary of samples tested using PCR, CELL, NT, HIST and IHC in
three Norwegian fish farms, Sites 1–3, investigated for PD in Salmo salar L.
Number of test positive samples (%)
Included PCR CELL NT HIST IHC
samples Ct < 40 (%) + (%) + (%) + (%) + (%)
All sites 268 101 (38) 67 (25) 56 (21) 50 (19) 3 (1)
Site 1 91 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Site 2 81 72 (89) 66 (81) 5 (6) 45 (56) 3 (4)
Site 3 96 29 (30) 1 (1) 51 (53) 5 (5) 0 (0)
RESULTS
Summary of Test Results
In total, 268 of the 300 collected samples were analyzed and
included in the study, while the remaining 32 samples were
excluded due to a lack of relevant tissue type or inadequate quality
of preservation.
An overview of the sample results for each site, and all sites
combined, is presented in Table 4. Test results varied across the
three sites and between the five tests. For Site 1, no samples were
test-positive by any of the tests. For Site 2, 89% of samples were
positive by PCR, followed by CELL (81%), histopathology (56%),
NT (6%) and IHC (4%). For Site 3, 53% of samples tested positive
by NT, followed by PCR (30%), HIST (5%), and CELL (1%). No
samples from Site 3 tested positive by IHC.
The combination of all obtained test results in the study is
shown in Table 5. For samples from Site 2, which was assumed to
have the highest prevalence of infected individuals in the study,
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TABLE 5 | Diagnostic test result combinations and associated results for PCR,
CELL, NT, HIST, and IHC across three Norwegian fish farms, Sites 1–3,
investigated for PD in Salmo salar L.
Test combinations Total
Test PCR + + + + + + + + – – – –
CELL + + + + + – – – – – – –
NT + + – – – + + – + + – –
HIST + – + + – + – – + – + –
IHC – – + – – – – – – – – –
Site All sites 4 2 3 37 21 2 24 8 3 21 1 142 268
Site 1 0 0 0 0 0 0 0 0 0 0 0 91 91
Site 2 4 1 3 37 21 0 0 6 0 0 1 8 81
Site 3 0 1 0 0 0 2 24 2 3 21 0 43 96
Only positive counts of the test combinations are shown here (12/32). Test combinations
that had no counts have not been included in the table (20/32). Table adapted from
Jaramillo et al. (6).
90% of samples were classified as positive by at least one test.
In comparison, 55% of samples from Site 3 were found to test
positive by at least one test.
Bayesian Estimation of Diagnostic
Sensitivity and Specificity
All models converged and showed no sign of autocorrelation with
the exception of model 7. Model 7 showed bimodal posterior
estimates; however, the model converged after restricting all DSp
priors to be at least 0.5. Gelman-Rubin statistics of all model
parameters were around 1. The posteriors estimates (median and
95% probability interval) of DSe, DSp and site prevalence based
on the 3-populations models are presented in Table 6, and the
results based on 2-populations models are presented in Table 7.
Outputs fromOpenBUGS including node statistics, density plots,
plots of Gelman-Rubin diagnostic and plots of autocorrelation of
all models are provided in the Supplementary Information.
The posterior estimates of site prevalence, DSe and DSp
were very similar across all 3-populations models (Table 6). The
posteriors estimates showed a very low probability of infection
for Site 1, a high prevalence with a narrow probability interval for
Site 2, and a low prevalence with a moderate probability interval
for Site 3. In model 1, PCR had the highest DSe (0.978) followed
by CELL (0.950) and HIST (0.637). Two tests, NT (0.085)
and IHC (0.051), were not considered functional as their DSe
estimates were very low. The DSe estimates of PCR and CELL
had narrow probability intervals (0.912–0.999 and 0.856–0.996,
respectively) giving a high certainty in the obtained estimates. In
contrast, a larger uncertainty was observed for the DSe estimate
of HIST (0.517–0.747). As for DSp, IHC (0.996) andCELL (0.993)
yielded high DSp estimates with narrow probability intervals
(0.981–0.999 and 0.972–0.999, respectively). HIST also had a high
DSp estimate (0.967) with a slightly wider probability interval
(0.936–0.986). PCR had a moderate DSp estimate (0.831) and
NT (0.744) the lowest DSp estimate. DSe and DSp based on the
models 2, 3, and 4 yielded consistent results with those obtained
in model 1. Figure 1 shows boxplots of posterior estimates of all
DSe and DSp based on model 1. TA
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The covariance estimates between PCR and CELL and
between HIST and IHC showed a very low test dependency
between the pairs, where the highest covariance of the DSe
estimate was 0.002 for the pair IHC and HIST and the highest
covariance of the DSp estimate was 0.008 for the pair IHC
and HIST.
For posterior estimates based on 2-populations models
(Table 7), the model without site 3 (model 5) and the model
without site 1 (model 6) had similar results compared to the 3-
populations models (Table 6) regarding to site prevalence and
DSp estimates. The model without site 2 (model 7), on the other
hand, showed a considerable difference in DSe estimates. As
for DSp, the model with 2-populations yielded very high DSp
estimates, except for model 6 which had low estimates of DSp
for PCR (0.686) and DSp for NT (0.546).
Difference in DSe and DSp Between Tests
For DSe, all pairs of the tests showed significant differences in
their DSe estimates; except the pair of PCR and CELL and the
pair of NT and IHC. The probability that PCR had a higher DSe
estimate than CELL was 0.7913. The probability that NT had a
higher DSe estimate than IHC was 0.7916. For DSp, the only
non-significant difference was the pair of IHC and CELL. The
probability that IHC had a higher DSp estimate than CELL was
0.649. A table containing the outputs from the Step function is
available in the Supplementary Information.
Sensitivity Analysis
No site prevalence, DSe or DSp estimates were sensitive to
changes in the priors of the models with 3-populations. Figure 2
shows caterpillar plots comparing the posterior estimates based
on model 1, while the caterpillar plots based on models 2, 3, and
4 are available in the Supplementary Information.
DISCUSSION
This study evaluated the performance of five different diagnostic
tests (real-time RT-PCR, CELL, histopathology, NT, and IHC)
for detection of SAV infection and histopathological changes
consistent with SAV infection in farmed Atlantic salmon, as listed
in the chapter on infection with SAV in the OIE Manual of
Diagnostic Tests for Aquatic Animals (20). All tests are direct,
independent tests for the presence of SAV, with the exception of
histopathology which detects tissue lesions as a sequela of SAV
infection. In the current study the tests were applied to three
different salmon farming sites, of which Site 1 was known to
be free from SAV infection. Sites 2 and 3 were known to be
infected by two different SAV genotypes and were assumed to
be at different stages of infection. For the tests used, the SAV-
genotype should not directly influence the test DSe and DSp
although the infections themselves may behave differently in the
infected populations, which may affect the test outcome.
When the tests were applied to a population considered free
from SAV infection (Site 1) all tests performed well, and no
sample was suggested SAV-positive by any of the test methods.
When tests were applied to the infected populations, as expected,
the test results from Site 2 and Site 3 showed that the two
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FIGURE 1 | Boxplots of the posterior estimates based on model 1. se[1] = DSe of PCR, se[2] = DSe of CELL, se[3] = DSe of NT, se[4] = DSe of HIST, se[5] = DSe of
IHC, sp[1] = DSp of PCR, sp[2] = DSp of CELL, sp[3] = DSe of NT, sp[4] = DSp of HIST, sp[5] = DSp of IHC.
sites differed in their infection stage allowing us to investigate
the diagnostic test performance using a Bayesian method. In
our main model (model 1), all samples from the three different
populations were compared to each other within the five-test
panel. In this model, real-time RT-PCR was found to have the
highest DSe. Real-time RT-PCR is commonly used as a screening
test to determine the infection status of a population at on-
growing seawater sites in salmonid aquaculture, and our results
from this model support this as the method of choice for this
purpose. Furthermore, isolation in cell culture was also found
to have high DSe and DSp. While being more time-consuming
and less suitable for screening purposes, an isolation in cell
culture detects the presence of viable SAV-particles and not
sections of genetic material only. A positive result indicates
that the population may be active shedders of viral particles
and thereby constitute a risk to naïve populations in the area.
Models 2, 3, 4, 5, and 6 showed a close similarity in DSe to
Model 1, with real-time RT-PCR having the highest DSe followed
by isolation in cell culture and histopathology, respectively.
SAV prevalence and DSp estimates are similar across the 3-
populations models.
The consistent results for the posterior estimates across
all the 3-populations models support the idea that these 3-
populations models are more robust than the 2-populations
models. Removing one population reduced the data by about
33%, which should significantly affect the estimates if the
removed population provided a substantial contribution to the
parameter estimates. When Site 1 was removed (model 6), the
model became non-identifiable and required an informative
prior for DSp. Similarly, when removing site 2 the model
required informative priors for DSe. Our observation is in
agreement with Berkvens et al. (32) and Dendukuri et al. (33) that
adding constraints or using informative priors to some model
parameters could provide a solution for a non-identifiable model.
The only previously published study on the DSe and DSp of
real-time RT-PCR (head kidney) and cell culture (heart ventricle
and heart kidney) for SAV were performed on samples from
a Scottish outbreak of PD caused by SAV 1 (34). While the
DSp estimates obtained were above 99% for both tests, the
estimates for DSe were 50% (95% CI: 41–62%) for cell culture
and 39% (95% CI: 31–49%) for real-time RT-PCR, respectively.
This DSe are lower than those observed in the current study
and could be due to the previous study not including heart
tissue in the sampled material, an organ which should always be
included when sampling for SAV detection according to the OIE
manual (20). While not yet in common use in Norway, portable
field kits for screening purposes are becoming available for a
rapidly increasing range of infections agents in aquatic animals. A
recent publication evaluated the DSe and DSp of a commercially
available, portable field kit for SAV detection, which was found
to have acceptable DSe and DSp although the reproducibility
was somewhat reduced compared to the accredited in-laboratory
method (35).
While none of the sites had a clinical outbreak of PD
detectable by observation at the time of sampling, or prior to
the time of sampling for Site 3, there were some important
differences between the sites. Site 2 was sampled in the same
month as the PD diagnosis was obtained, however as this area
did not have compulsory screening for SAV the actual month of
infection remains unknown. Site 3 was sampled 4 months after
the diagnosis, however as this site was located in an area where
compulsory screening was in place it is likely that the site was only
infected shortly before the diagnosis was confirmed. While both
experimental (16) and field (15) studies have shown differences
between the two Norwegian SAV genotypes in the severity of the
resultant clinical outbreaks, other biological factors influencing
diagnostic test functionality appears to be relatively genotype-
unspecific. A Norwegian experimental study found 57% of SAV2
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FIGURE 2 | Caterpillar plots of the posterior estimates based on model 1. pi[1] = Site 1 prevalence, pi[2] = Site 2 prevalence, pi[3] = Site 3 prevalence, se[1] = DSe
of PCR, se[2] = DSe of CELL, se[3] = DSe of NT, se[4] = DSe of HIST, se[5] = DSe of IHC, sp[1] = DSp of PCR, sp[2] = DSp of CELL, sp[3] = DSe of NT, sp[4] =
DSp of HIST, sp[5] = DSp of IHC.
cohabitant fish and 84% of SAV3 cohabitant fish to test positive
by real-time RT-PCR at 2 weeks post-infection, which increased
to 98% (regardless of SAV genotype) by week 3 and remained
close to 100% until the end of the experiment (week 12) (16).
Previous studies suggest that a prolonged positive PCR signal
can be found in infected populations (36) and that populations
remain positive until slaughter even when infected early during
the seawater phase (24, 37). However, the prevalence of positive
individuals decreased in some cases over time following the
outbreak (24, 37). A recent Norwegian study sampling three
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Atlantic salmon populations at 2 weeks, 5, and 14 months after
SAV2 detection, respectively, identified some individuals that
tested positive for SAV2-RNA in red muscle tissue while the
heart tissue tested negative (38). While scientific findings suggest
that a PCR-positive population should test SAV-positive by real-
time RT-PCR analyses at a population level at all times between
infection and slaughter, there may be a reduced sensitivity at the
individual fish level if not screening additional tissues later in the
infection, perhaps particularly for SAV2 with its milder clinical
course. It may be that a slower spread of SAV2 through the
population, or the lack of tested muscle tissue for Site 3, accounts
for the lower prevalence estimate obtained for this population
despite it having been infected for several months.
The Norwegian experimental study of SAV2 and SAV3 found
the onset of histopathological lesions from week 4 post-infection,
with more than half of the fish still having SAV-related tissue
changes as detected by histopathological examination at 12
weeks post-infection (16). Histopathological changes appear to
be similar regardless of underlying SAV genotype (16, 17) and
genotype should therefore be unlikely to affect the DSe and DSp
of this test. The inherent biological variation in tissue lesions and
the human factor of interpreting the range of possible changes
likely account for the larger probability intervals obtained for the
DSe and DSp estimates for this test method.
The NT is aimed at detecting antibodies/neutralizing activity
against SAV in serum. High seroprevalences of virus neutralizing
antibodies have been reported from studies of natural PD
outbreaks (24, 37, 39), with the majority of populations
remaining seropositive until slaughter (24, 37). No differences
in virus titres or antibody levels were detected when comparing
SAV2 and SAV3 experimental infections (16), suggesting that
SAV-genotype differences are not the underlying reason for the
observed result. The NT test performed particularly well for Site
3 (SAV2) which was sampled several months after diagnosis,
and the failure to detect infectious virus particles by isolation
in cell culture supports the interpretation that the population
at this site was in a later stage of infection. It furthermore
supports the assumption that Site 2 (SAV3) was infected relatively
shortly before sampling, as research indicates that blood serum
or plasma is suitable for a virus neutralization test that identifies
neutralizing antibodies against SAV from ∼3 weeks after SAV
infection (26). It also highlights NT as a potential method for
non-lethal screening of SAV exposure, whichmay be of particular
relevance in the screening of larger, high-value salmon. However,
the specificity of the NT test can be an issue, as cross-reactivity
between PRV-1 and SAV has been demonstrated (40) In addition,
vaccination against SAV, which is common in the endemic
SAV3 area, will affect the results of the NT test. Successful
vaccination against SAV will produce neutralizing antibodies of
varying levels dependent on the vaccine type used, the efficacy
of the vaccination and the time lag between vaccination and
testing. In vaccinated fish, this test therefore has to be used
with caution, and a positive result can only be interpreted
as an indication of infection and not used as a confirmatory
diagnostic test.
To our knowledge this is the first scientific publication of a
field validation of the five major diagnostic tests recommended
for SAV detection in accordance with the OIE Manual of
Diagnostic Tests for Aquatic Animals (9). The OIE Manual lists
recommended diagnostic methods for presumptive diagnosis,
confirmatory diagnosis and targeted surveillance for SAV, and
categorize the different methods based on availability, utility,
and diagnostic sensitivity and specificity (20). While stating that
these categorisations are somewhat subjective, the OIE concludes
that the diagnostic tests classified as recommended methods and
standard methods are acceptable due to their routine nature
and the fact that they have been widely used without dubious
results (20). For presumptive diagnosis histopathology and serum
neutralization assay are listed as recommended methods while
immunohistochemistry, real-time RT-PCR and RT-PCR with
sequencing are listed as standard methods. For confirmatory
diagnosis histopathology and RT-PCR with sequencing are
recommended methods and immunohistochemistry, serum
neutralization assay and real-time RT-PCR standard methods.
For targeted surveillance real-time RT-PCR is listed as a
standard method across fish life stages (fry, juveniles, and adults)
(20). Field validation of diagnostic tests assesses the entire
procedure from fish selection and sample collection to laboratory
procedures, with each step potentially contributing to a reduction
of the DSe and/or DSp. In our study, tissue samples included
heart ventricle and mid-kidney, the recommended organs for the
detection of SAV (2). The assessments of the real-time RT-PCR
method for SAV were in accordance with that stipulated in the
OIE manual (20), where it is listed as a standard method and is
the method with highest ranking as a universal diagnostic test.
Assessment of the analytical sensitivity (the limit of detection)
and analytical specificity (the ability to detect the target sequence
only) of the QnsP1 assay has shown it to be highly sensitive
and specific with an ability to detect <0.1 TCID50 of virus
stocks, with reproducible results at different RNA concentration
levels (23), with a more recently developed assay reported to
be 100 times more sensitive (41). Due to its application as a
screening tool, and the potential consequences of false positive
and false negative results, the DSe and DSp of real-time RT-PCR
is of particular interest. A positive result (whether true or
false) may be disputed by a range of stakeholders, in particular
where the SAV-detection results in implementation of mitigation
measures leading to economic losses and business interruption.
While it was shown to perform well in the main model and
in a recently infected population it showed a lower DSe in a
population at a later stage of infection. A false negative result
will be of particular importance in two scenarios: where the
test-negative population sheds virus, or where the population is
destined for export and subjected to import tests where SAV-
RNA detection results in goods rejection and possibly subsequent
trade sanctions.
In the case of a weak positive result, a follow-up test should be
conducted in order to verify the presence of the infectious agent.
In the case of SAV, isolation in cell culture, which was found to
have high DSe and DSp in more recently infected populations,
may be used to verify viral presence. Similarly, follow-up tests
may be appropriate in cases where a negative PCR result is
obtained from a population where the available epidemiological
information suggest a high probability of infection. In this case,
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follow-up tests of serum samples may be appropriate in order
to evaluate and monitor infection status. This is of particular
relevance in cases where the consequences of false negative
results are high, such as in cases of potential spread to previously
non-infected areas or in relation to trade. Histopathological
examination is an important test for identifying lesions associated
with the agent of interest but also as a test for important
differential diagnoses and passive surveillance. Based on our
samples, IHC demonstrated both a limited DSe and DSp, which
is as expected as the test is only recommended for samples from
fish with acute necrosis of exocrine pancreatic tissue in the OIE
manual (9).
Our results confirms that the evaluated tests ability correctly to
detect SAV or the resultant disease is dependent on the infectious
status of the population in question. To achieve the most reliable
results for different situations such as early detection, monitoring
prevalence and documentation of disease freedom, a thorough
consideration of the appropriate method(s) has to be done at the
beginning of the testing program.
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